GEN-MKT-18-7897-A
Mar 16, 2018 | Blogs, Software, Technology | 0 comments
Make the Most out of Your People and InstrumentationUnless you’re running samples, you’re losing revenue. Even if you’re not charging your customers for sample runs, your operating costs rise like a rocket when your instruments are down. Therefore, instrument downtime is a significant concern for most labs.
After polling SCIEX users, we found that labs that used the SCIEX remote monitoring service found that up to 50 percent of their instrument issues could be resolved remotely.
These users spent much less time waiting for a service engineer to arrive on site, diagnose and repair the problem.
SCIEX LC-MS systems already have exceptional uptime, but reclaiming a day of productivity means your instruments are running samples that would otherwise be waiting.
Based on a number of samples run per day and cost or revenue per sample, even a 1% increase in uptime could save you thousands of dollars!
Mass Spec Remote Monitoring Services Enable Your Lab to:
How often have you had to postpone operations while waiting for a service call?Perhaps you are familiar with the advantages of remote monitoring services but have difficulty convincing your management of their value.
Remember, remote monitoring services simply cannot be beaten when it comes to obtaining reports on instrument utilization, performance, uptime, and sample throughput.
With remote monitoring, your team can monitor the current health your system efficiently. That means you are already in the know when things are amiss.
When an instrument requires an onsite fix, an engineer spends less time diagnosing the problem and more time actually fixing the problem, which can save your lab hours or days of downtime.
Clearly, remote monitoring enhances your organization’s competitive advantage. Better productivity, better efficiency, and most of all lower costs and higher revenue
Want to leverage tools that help you win? Check out StatusScope® Remote Monitoring. Start benefitting from useful reports on throughput, productivity and asset utilization on all your SCIEX mass spectrometers, everywhere.
In biopharmaceutical development, sequence variants (SV) are considered an inherent risk of producing complex proteins in living systems. Sequence variants are unintended changes to the amino acid sequence of a biotherapeutic and can be caused by errors in transcription or translation in the host cell, or cell culture and process conditions. Detailed analysis of SVs is important in process and product development to ensure the drug’s safety and efficacy. Even low‑level sequence variants can have significant implications for product quality, safety, and efficacy, making their accurate detection and characterization a critical requirement across development, process optimization, and regulatory submission.
CE‑SDS remains a cornerstone assay for characterizing fragmentation, aggregation, and product‑related impurities in therapeutic proteins. UV detection has been the long‑standing standard. However, it frequently struggles with baseline noise, limited sensitivity for minor fragments, and subjective integration.
At SCIEX, innovation doesn’t stop at instruments; it extends to how you interact with your LC-MS/MS or CE systems every day. That’s why we’re excited to introduce the SCIEX Now spring 2026 improvements: a set of meaningful enhancements shaped directly by your feedback.
Posted by
You must be logged in to post a comment.
Share this post with your network